Pulmonary Embolism
📧 Sign up to get email alerts when something new happens for Pulmonary Embolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Mechanical Respiratory/circulatory Support in Patients with Pulmonary Thrombectomy
Completed clinical trial assessing mechanical respiratory and circulatory support in patients following pulmonary thrombectomy.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Evaluating the Potential of Large Language Models for Respiratory Disease Consultations [NA]
This completed clinical trial evaluated the potential of large language models to assist respiratory disease consultations. It covered multi…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Microvisk Continuous Blood Donation Study [NA]
Clinical trial update from Microvisk Technologies Ltd indicates a study on pulmonary embolism, deep vein thrombosis, and atrial fibrillation…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism [Phase 3]
Phase 3 clinical trial evaluating low-dose thrombolysis, ultrasound-assisted thrombolysis, and heparin for intermediate-high risk pulmonary …
-
CLINICAL_TRIALS withdrawal · 2024-11-15Clinical Trial Update: Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis [NA]
A pediatric clinical trial investigating exercise intolerance and skeletal muscle bioenergetics in children with deep vein thrombosis and pu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-13Clinical Trial Update: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm
The trial evaluating the XAPPORT decision-support app for managing anticoagulation in patients treated with rivaroxaban undergoing elective …
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT) [NA]
This clinical trial is evaluating whether the residual pulmonary vascular obstruction index computed from ventilation/perfusion SPECT/CT can…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Safe Delivery of Thrombolytic Treatment for Pulmonary Embolism Using ClotPro® Viscoelastic Tests [NA]
Completed clinical trial evaluating safe delivery of thrombolytic therapy for pulmonary embolism guided by ClotPro viscoelastic tests.
-
FDA approval · 2024-10-24FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indication…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
A completed clinical trial update investigating biomarkers and clinical predictive models for pulmonary embolism in pregnancy.
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE [Phase 4]
Phase 4 clinical trial update comparing peripheral systemic thrombolysis versus catheter-directed thrombolysis for submassive pulmonary embo…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: FlowTriever for Acute Massive Pulmonary Embolism (FLAME)
The FLAME trial evaluating the FlowTriever System for acute massive pulmonary embolism has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries [NA]
A completed clinical trial assessing bemiparin as thromboprophylaxis after gynecological surgery.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: iMRI Prone Positioning Frame Design Feasibility Study [NA]
A feasibility study evaluating an iMRI prone positioning frame design, sponsored by the University of Kansas Medical Center; the trial is no…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
Clinical trial update on a study evaluating ultrasound assessment of isolated distal deep vein thrombosis. The sponsor is Ruijin Hospital, a…
-
EMA approval · 2024-09-12EMA Authorised: Xarelto (rivaroxaban) — Bayer AG
The European Medicines Agency authorised Xarelto (rivaroxaban) for the prevention of venous thromboembolism in patients undergoing arthropla…
-
FDA approval · 2024-09-11FDA Approved: DABIGATRAN ETEXILATE — Original Application (Major Pharmaceuticals)
The FDA approved an original application for dabigatran etexilate (generic) from Major Pharmaceuticals. It covers indications such as nonval…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: The Prognostic Value of Anion Gap in Predicting Mortality Among Patients With Acute Pulmonary Embolism
A clinical trial is investigating whether the anion gap can predict mortality in patients with acute pulmonary embolism and is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism
This entry reports that a clinical trial investigating exploratory metabolomics of exhaled breath in pulmonary embolism has been terminated.
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Chinese PE Multimodality Imaging Artificial Intelligence Study
Clinical trial update for a Chinese multimodality imaging AI study focused on pulmonary embolism and chronic thromboembolic pulmonary hypert…
-
FDA approval · 2024-08-16FDA Approved: DABIGATRAN ETEXILATE — Supplemental Application (Major Pharmaceuticals)
The FDA approved a supplemental application for dabigatran etexilate (generic) submitted by Major Pharmaceuticals.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Nurses' Health Study (Cardiovascular Component)
The Nurses' Health Study cardiovascular component is currently active but not recruiting, with conditions including cardiovascular diseases …
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
This clinical trial update reports on outcomes of patients who survived ICU treatment for COVID-19 in England and Wales.
-
FDA approval · 2024-08-13FDA Approved: DABIGATRAN ETEXILATE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved XLCare Pharmaceuticals' original application for dabigatran etexilate (generic), confirming a generic version of the anticoagul…
-
FDA approval · 2024-08-12FDA Approved: DABIGATRAN ETEXILATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original application for dabigatran etexilate, a generic anticoagulant. It is used to reduce stroke ri…